検索条件

閉じる

検索結果 469 件

フルテキストURL fulltext.pdf
著者 Chen, Youyi| Sumardika, I Wayan| Tomonobu, Nahoko| Kinoshita, Rie| Inoue, Yusuke| Iioka, Hidekazu| Mitsui, Yosuke| Saito, Ken| Ruma, I Made Winarsa| Sato, Hiroki| Yamauchi, Akira| Murata, Hitoshi| Yamamoto, Ken-ichi| Tomida, Shuta| Shien, Kazuhiko| Yamamoto, Hiromasa| Soh, Junichi| Futami, Junichiro| Kubo, Miyoko| Putranto, Endy Widya| Murakami, Takashi| Liu, Ming| Hibino, Toshihiko| Nishibori, Masahiro| Kondo, Eisaku| Toyooka, Shinichi| Sakaguchi, Masakiyo|
発行日 2019-07
出版物タイトル Neoplasia
21巻
7号
開始ページ 627
終了ページ 640
ISSN 1522-8002
NCID AA11470191
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2019 The Authors.
論文のバージョン publisher
PubMed ID 31100639
DOI 10.1016/j.neo.2019.04.006
Web of Science KeyUT 000472189700001
関連URL isVersionOf https://doi.org/10.1016/j.neo.2019.04.006
タイトル(別表記) Current topics in hereditary breast and ovarian cancer
フルテキストURL 131_89.pdf
著者 大住 省三 |
キーワード 遺伝性乳癌卵巣癌 遺伝学的検査 PARP阻害薬 multi-gene panel 検査
出版物タイトル 岡山医学会雑誌
発行日 2019-08-01
131巻
2号
開始ページ 89
終了ページ 96
ISSN 0030-1558
関連URL isVersionOf https://doi.org/10.4044/joma.131.89
言語 日本語
著作権者 Copyright (c) 2019 岡山医学会
論文のバージョン publisher
DOI 10.4044/joma.131.89
NAID 130007700794
タイトル(別表記) Our approach to cancer genomic medicine at Okayama University Hospital
フルテキストURL 131_41.pdf
著者 豊岡 伸一 | 冨田 秀太 |
キーワード がんゲノム医療 岡山大学病院 プレシジョンメディスン
出版物タイトル 岡山医学会雑誌
発行日 2019-04-01
131巻
1号
開始ページ 41
終了ページ 43
ISSN 0030-1558
関連URL isVersionOf https://doi.org/10.4044/joma.131.41
言語 日本語
著作権者 Copyright (c) 2019 岡山医学会
論文のバージョン publisher
DOI 10.4044/joma.131.41
NAID 130007642653
JaLCDOI 10.18926/AMO/56937
フルテキストURL 73_4_349.pdf
著者 Isozaki, Hiroshi| Yamamoto, Yasuhisa| Murakami, Shigeki| Matsumoto, Sasau| Takama, Takehiro|
抄録 To clarify the surgical outcomes of breast cancer patients with a preoperative diagnosis of ductal carcinoma in situ (DCIS) by core needle biopsy (CNB) (abbreviated as CNBDCIS), we retrospectively analyzed the cases of 131 patients with CNBDCIS who underwent surgery at Oomoto Hospital (32 total mastectomies, 99 conservative mastectomies). Our analysis of underestimation and predictors of invasive breast cancer of CNBDCIS revealed that the underestimation rate of CNBDCIS was 40.5% (53/131). A logistic regression analysis revealed that palpable tumors (yes to no, odds ratio [OR] 3.25), mammography (MMG) category group (category 4 or 5 to categories 1 , 2, or 3, OR 4.69) and MMG microcalcifications (no to yes, OR 0.24) were significant predictive factors for CNBDCIS invasion. In our analysis of the predictors of positive margins during CNBDCIS surgery, 36 (27.5%) of the 131 patients had positive margins after postoperative pathological examination. A logistic regression analysis revealed that the operative procedure (conservative surgery to total mastectomy, OR 21.4) and MMG microcalcifications (yes to no, OR 3.35) were significant factors related to positive margins during CNBDCIS surgery. Thus, MMG microcalcifications are a negative predictor of upgrading of CNBDCIS and a positive predictor of positive surgical margins for CNBDCIS.
キーワード ductal carcinoma in situ core needle biopsy underestimation positive margins microcalcifications on mammography
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2019-08
73巻
4号
出版者 Okayama University Medical School
開始ページ 349
終了ページ 356
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2019 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 31439958
JaLCDOI 10.18926/AMO/56930
フルテキストURL 73_4_285.pdf
著者 Otani, Yoshihiro| Ichikawa, Tomotsugu| Kurozumi, Kazuhiko| Date, Isao|
抄録 Gliomas are characterized as highly diffuse infiltrating tumors, and currently available treatments such as surgery, radiation and chemotherapy are unfeasible or show limited efficacy against these tumors. Recent genetic and epigenetic analyses of glioma have revealed increasing evidence of the role of driver genetic alterations in glioma development and led to the identification of prognostic factors. Despite these findings, the survival rates of glioma patients remain low, and alternative treatments and novel targets are needed. Recent studies identified neural stem cells as the possible origin of gliomas, and some evidence has revealed shared functions and mechanisms between glioma cells and neurons, also supporting their similarity. The cytoskeleton plays important roles in the migration of normal cells as well as cancer cells. Recent reports have described a role for microtubules, a component of the cytoskeleton, in glioma invasion. Notably, several factors that regulate microtubule functions, such as microtubule-associated proteins, plus-end tracking proteins, or motor proteins, are upregulated in glioma tissues compared with normal tissue, and upregulation of these factors is associated with high invasiveness of glioma cells. In this review, we describe the mechanism of microtubules in glioma invasion and discuss the possibility of microtubule-targeted therapy to inhibit glioma invasion.
キーワード glioma cytoskeletons invasion microtubules
Amo Type Review
出版物タイトル Acta Medica Okayama
発行日 2019-08
73巻
4号
出版者 Okayama University Medical School
開始ページ 285
終了ページ 297
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2019 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 31439951
JaLCDOI 10.18926/AMO/56458
フルテキストURL 73_1_51.pdf
著者 Fujii, Masakuni| Fujimoto, Kenji| Yabe, Syuntaro| Nasu, Junichiro| Miyaike, Jiro| Yoshioka, Masao| Shiode, Junji| Yamamoto, Kazuhide| Matsuda, Shinya|
抄録  We investigated the relationship between body mass index (BMI) and postoperative outcomes in 450 gallbladder cancer patients in Japan. We collected patient information, including sex, age, underlying disease, BMI, stage, surgery method, postoperative time to discharge, and postoperative Medicare fees, from the Japanese administrative database associated with the Diagnosis Procedure Combination system. We classified patient BMIs as underweight (BMI<18.5 kg/m2), normal (BMI≥18.5 kg/m2 and <25 kg/m2) or overweight/obese (BMI≥25 kg/m2), then investigated the relationship between these categories and two postoperative outcomes: time to discharge and postoperative Medicare fees. The median postoperative time to discharge was 12 days in all patients, and 12 days in each of the three weight groups (p=0.62, n.s.). The median postoperative Medicare fees from surgery until discharge were (USD): all patients, $5,002; underweight, $5,875; normal weight, $4,797; and overweight/obese, $5,179 (p=0.146, n.s.). A multivariate analysis with adjustment for competing risk factors revealed that BMI was not associated with increased risk of longer postoperative time to discharge (normal weight: HR 1.17, p=0.29; overweight/obese: HR 1.17, p=0.37) or higher postoperative Medicare fees (OR 0.99, p=0.86, n.s.). Thus, high BMI was not found to be a factor for poor postoperative outcomes in Japanese patients with gallbladder cancer.
キーワード body mass index gallbladder cancer surgery obesity
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2019-02
73巻
1号
出版者 Okayama University Medical School
開始ページ 51
終了ページ 59
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2019 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 30820054
JaLCDOI 10.18926/AMO/56249
フルテキストURL 72_5_507.pdf
著者 Ogata, Takeshi| Katsui, Kuniaki| Yoshio, Kotaro| Ihara, Hiroki| Katayama, Norihisa| Soh, Junichi| Kuroda, Masahiro| Kiura, Katsuyuki| Maeda, Yoshinobu| Toyooka, Shinichi| Kanazawa, Susumu|
抄録 To clarify the relationship between dose-volume histogram (DVH) parameters and radiation pneumonitis (RP) after surgery in cases of non-small cell lung cancer (NSCLC) treated with induction concurrent chemoradiotherapy (CCRT). Patients with NSCLC treated with induction CCRT (chemotherapy: cisplatin and docetaxel; radiotherapy: 2.0 Gy fractions once daily for a total of 46 Gy) before surgery were reviewed. We calculated the percentage of lung volume receiving at least 20 Gy (V20) and the mean lung dose (MLD) for the total lung volume and the lung remaining after resection. Factors affecting the incidence of RP at grade 2 or higher (≥ G2 RP) were analyzed. Eighteen of 49 patients (37%) experienced ≥G2 RP. The V20 and MLD for the lung remaining after resection (V20r and MLDr) were significant predictors according to the multivariate analysis (p=0.007 and 0.041, respectively). The incidence of ≥G2 RP was 8% in patients with V20r<10%, and 13% in patients with MLDr<5.6 Gy, respectively. The optimal approach to reduce the rate of postoperative RP in patients with induction CCRT for NSCLC is to keep the V20r below 10% and/or the MLDr below 5.6 Gy in the radiotherapy planning.
キーワード radiation pneumonitis V20 mean lung dose induction chemoradiotherapy non-small cell lung cancer
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2018-10
72巻
5号
出版者 Okayama University Medical School
開始ページ 507
終了ページ 513
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2018 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 30369608
JaLCDOI 10.18926/AMO/56172
フルテキストURL 72_4_369.pdf
著者 Iwamoto, Takayuki| Taira, Naruto| Fujisawa, Tomomi| Araki, Kazuhiro| Sakamaki, Kentaro| Sangai, Takafumi| Kikawa, Yuichiro| Shien, Tadahiko| Takao, Shintaro| Sato, Masako| Goto, Yoshinari| Yoshida, Takashi| Takahashi, Masato| Aihara, Tomohiko| Mukai, Hirofumi|
抄録 The Hormonal therapy resistant estrogen-receptor positive metastatic breast cancer cohort (HORSE-BC) study is a multicenter observational study evaluating the efficacy and safety of secondary endocrine therapy (ET) for postmenopausal cases of metastatic breast cancer (MBC) with poor response to primary ET. In this initial report we analyze the HORSE-BC baseline data to clarify the current status of treatment selection for MBC in Japan. Baseline data for the 50 patients enrolled in HORSE-BC were analyzed, including patient characteristics, types of secondary ET, and reasons for selecting secondary ET. Postoperative recurrence was detected in 84% of patients (42/50) and de novo stage IV breast cancer in 16% (8/50). Forty-one patients (41/50; 82%) received fulvestrant, 5 patients (10%) received selective estrogen receptor modulators (SERMs), 3 patients (6%) received ET plus a mammalian target of rapamycin (mTOR) inhibitor, and 1 patient received an aromatase inhibitor (AI) as the secondary ET. Forty-five patients selected their secondary ET based on its therapeutic effect, while 14 patients selected it based on side effects. Most patients with progression after primary ET selected fulvestrant as the secondary ET based on its therapeutic and side effects. We await the final results from the HORSE-BC study.
キーワード breast cancer secondary endocrine therapy low sensitivity primary endocrine therapy fulvestrant
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2018-08
72巻
4号
出版者 Okayama University Medical School
開始ページ 369
終了ページ 374
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2018 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 30140084
JaLCDOI 10.18926/AMO/56167
フルテキストURL 72_4_331.pdf
著者 Miyahara, Kanae| Kuroda, Masahiro| Yoshimura, Yuuki| Aoyama, Hideki| Oita, Masataka| Sugianto, Irfan| Matsuzaki, Hidenobu| Ihara, Hiroki| Katayama, Norihisa| Katsui, Kuniaki| Kanazawa, Susumu| Asaumi, Junichi|
抄録 We used image-processing software to analyze the setup errors at the skin surface position of breast cancer patients (n=66) who underwent post-operative whole breast irradiation at our hospital in 2014-2015. The sixty-six digital reconstructed radiographs (DRR) were created at the treatment planning for each patient. The lineacgraphies (n=377) were taken after the patients’ setup during radiotherapy. The lineacgraphies and DRR were superimposed at the skin surface position for each patient with the image-processing software. We measured the deviations of the isocenters for the nipple-lung (X) direction and craniocaudal (Y) direction and the deviation of the rotation angle of the XY axes between the lineacgraphy and DRR on the superimposed images. The systematic error (μ, Σ) and random error (σ) were calculated from the X and Y deviations and rotation angle deviation. The μ of X, Y, and rotation angle were 0.01 mm, −1.2 mm, and 0.05°, respectively. The Σ of X, Y, and rotation angle were 1.8 mm, 1.5 mm, and 0.9°, respectively. The σ of X, Y, and rotation angle were 2.0 mm, 1.5 mm, and 1.0°, respectively. Our analyses thus revealed that evaluations using image-processing software at the skin surface position in routine breast radiotherapy result in sufficiently small setup errors.
キーワード breast cancer radiotherapy position verification skin surface image processing software
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2018-08
72巻
4号
出版者 Okayama University Medical School
開始ページ 331
終了ページ 336
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2018 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 30140079
フルテキストURL J_Cell_Biochem_116_10_2146.pdf
著者 Eguchi , Taka| Prince, Thomas| Wegiel, Barbara| Calderwood, Stuart K.|
キーワード CANCER FINGER-1 INVASION MYELOID NUCLEAR BODY SUMO ZINC
発行日 2015-04-21
出版物タイトル Journal of cellular biochemistry
116巻
10号
出版者 Wiley
開始ページ 2146
終了ページ 2154
ISSN 0730-2312
NCID AA1052210X
資料タイプ 学術雑誌論文
言語 日本語
OAI-PMH Set 岡山大学
論文のバージョン author
PubMed ID 25903835
DOI 10.1002/jcb.25203
Web of Science KeyUT 000359809400004
関連URL isVersionOf https://doi.org/10.1002/jcb.25203
タイトル(別表記) Metaplastic carcinoma of the breast : Two cases
フルテキストURL 130_19.pdf
著者 元木 崇之| 岩本 高行 | 大森 昌子| 松岡 順治|
抄録 We treated two patients with a rare metaplastic carcinoma of the breast. Patient 1:A 32-year-old woman presented with a rapidly growing mass( 7cm) in her right breast. We diagnosed cT3N0M0 Stage IIB breast cancer and performed a radical resection. The pathological diagnosis was triple-negative metaplastic carcinoma with a Ki-67 value >30%. Postoperative adjuvant chemotherapy and radiotherapy were performed. Patient 2:A 66-year-old postmenopausal woman presented with a left breast mass. We diagnosed cT1N0M0 Stage I breast cancer and performed a radical resection. The pathological diagnosis was triple-negative metaplastic carcinoma with a Ki-67 value >30%. Postoperative adjuvant chemotherapy was performed. Patients 1 and 2 have achieved relapse-free survivals of 1 year+2 months and 10 months, respectively. Metaplastic carcinoma of the breast is a rare tumor, and its prognosis is not favorable. The only available treatment is that used for invasive ductal carcinoma;a more specific treatment has not been established. The accumulation of further similar cases and the development of a novel effective treatment are desired.
キーワード 乳癌(breast cancer) 化生癌(metaplastic carcinoma) 化学療法(chemotherapy)
出版物タイトル 岡山医学会雑誌
発行日 2018-04-02
130巻
1号
開始ページ 19
終了ページ 23
ISSN 0030-1558
関連URL isVersionOf https://doi.org/10.4044/joma.130.13
言語 日本語
著作権者 Copyright (c) 2018 岡山医学会
論文のバージョン publisher
DOI 10.4044/joma.130.13
NAID 130006730866
タイトル(別表記) Adjuvant chemotherapy for non small-cell lung cancer
フルテキストURL 130_9.pdf
著者 豊岡 伸一 |
出版物タイトル 岡山医学会雑誌
発行日 2018-04-02
130巻
1号
開始ページ 9
終了ページ 12
ISSN 0030-1558
関連URL isVersionOf https://doi.org/10.4044/joma.130.9
言語 日本語
著作権者 Copyright (c) 2018 岡山医学会
論文のバージョン publisher
DOI 10.4044/joma.130.9
NAID 130006730889
フルテキストURL K0005767_abstract_review.pdf K0005767_summary.pdf K0005767_fulltext.pdf
著者 吉川 あゆみ|
発行日 2018-03-23
資料タイプ 学位論文
学位授与番号 甲第5767号
学位授与年月日 2018-03-23
学位・専攻分野 博士(看護学)
授与大学 岡山大学
言語 英語
フルテキストURL K0005687_abstract_review.pdf K0005687_summary.pdf K0005687_fulltext.pdf K0005687_figs.pdf
著者 河内 麻里子|
発行日 2018-03-23
資料タイプ 学位論文
学位授与番号 甲第5687号
学位授与年月日 2018-03-23
学位・専攻分野 博士(医学)
授与大学 岡山大学
言語 英語
JaLCDOI 10.18926/AMO/55860
フルテキストURL 72_2_185.pdf
著者 Morizane, Shin| Sugimoto, Saeko| Motoki, Takayuki| Katayama, Norihisa| Omori, Masako| Iwatsuki, Keiji|
抄録 Psoriasis is a common chronic inflammatory skin disorder that is characterized by scaly, erythematous, sharply demarcated plaques. The treatment for psoriasis has dramatically changed over the last 10 years with the introduction of biologics. However, the risk of cancer induced by biologics for psoriasis has not been fully analyzed, since these agents have such a short history of use. Here we report the case of a 74-year-old woman with psoriasis vulgaris and psoriatic arthritis complicated by breast cancer after systemic treatments including etretinate, cyclosporine, methotrexate, adalimumab, and ustekinumab.
キーワード psoriasis systemic therapy biologics malignancy
Amo Type Case Report
出版物タイトル Acta Medica Okayama
発行日 2018-04
72巻
2号
出版者 Okayama University Medical School
開始ページ 185
終了ページ 187
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2018 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 29674768
JaLCDOI 10.18926/AMO/55854
フルテキストURL 72_2_137.pdf
著者 Takahashi, Yuko| Shien, Tadahiko| Sakamoto, Ai| Tsuyumu, Yuko| Yoshioka, Ryo| Uno, Maya| Hatono, Minami| Kochi, Mariko| Kawada, Kengo| Tsukioki, Takahiro| Iwamoto, Takayuki| Ikeda, Hirokuni| Taira, Naruto| Matsuoka, Junji| Nakatsuka, Mikiya| Doihara, Hiroyoshi|
抄録 Adverse effects on fertility are a significant problem for premenopausal breast cancer patients. Since April 2009, we have been referring young patients for fertility counseling provided by a multidisciplinary team. Here we evaluated the efficacy and safety of our current fertility preservation approach. We retrospectively analyzed the cases of 277 patients < 45 years old at diagnosis, which was made between 2009 and 2016. Seventy-two (26%) patients received fertility counseling. Seventeen (6%) of the 277 patients decided to preserve their fertility before starting adjuvant systemic therapy. Six (35%) patients underwent oocyte cryopreservation, and 11 (65%) married patients opted for embryo cryopreservation. There were no pregnancies among the patients undergoing oocyte cryopreservation, whereas 3 (27%) of the patients who opted for embryo cryopreservation became pregnant. Two (12%) patients stopped endocrine therapy after 2 years in an effort to become pregnant, but their breast cancers recurred. Though the problem of fertility loss for breast cancer patients is important and we should assess the infertility risk for all patients, we should also consider the prognosis. In June 2016, we launched a prospective multicenter cohort study to evaluate the efficacy and safety of fertility preservation in greater detail.
キーワード fertility preservation multidisciplinary breast cancer young patients
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2018-04
72巻
2号
出版者 Okayama University Medical School
開始ページ 137
終了ページ 142
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2018 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 29674762
フルテキストURL K0005600_other1.pdf
著者 Takeda, Tatsuaki| Yamamoto, Hiromasa| Kanzaki, Hirotaka| Suzawa, Ken| Yoshioka, Takahiro| Tomida, Shuta| Cui, Xiaojiang| Murali, Ramachandran| Namba, Kei| Sato, Hiroki| Torigoe, Hidejiro| Watanabe, Mototsugu| Shien, Kazuhiko| Soh, Junichi| Asano, Hiroaki| Tsukuda, Kazunori| Kitamura, Yoshihisa| Miyoshi, Shinichiro| Sendo, Toshiaki| Toyooka, Shinichi|
備考 学位審査副論文|
発行日 2017-02-03
出版物タイトル PLoS One
12巻
2号
出版者 Public Library of Science
開始ページ e0171356
ISSN 1932-6203
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja
論文のバージョン publisher
PubMed ID 28158234
DOI 10.1371/journal.pone.0171356
Web of Science KeyUT 000396161700064
関連URL isVersionOf https://doi.org/10.1371/journal.pone.0171356 isPartOf http://ousar.lib.okayama-u.ac.jp/55525
フルテキストURL K0005596_other1.pdf
著者 Thar Htet San| Fujisawa, Masayoshi| Fushimi, Soichiro| Soe, Lamin| Ngu Wah Min| Yoshimura, Teizo| Ohara, Toshiaki| Myint Myint Yee| Oda, Shinsuke| Matsukawa , Akihiro|
キーワード Breast cancer molecular subtypes Ki-67 expression Myanmar
備考 学位審査副論文|
発行日 2017-06-25
出版物タイトル Asian Pacific journal of cancer prevention
18巻
6号
出版者 Asian Pacific Organization for Cancer Prevention
開始ページ 1617
終了ページ 1621
ISSN 1513-7368
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja
論文のバージョン publisher
PubMed ID 28670879
DOI 10.22034/APJCP.2017.18.6.1617
関連URL isVersionOf https://doi.org/10.22034/APJCP.2017.18.6.1617 isPartOf http://ousar.lib.okayama-u.ac.jp/55521
フルテキストURL K0005596_abstract_review.pdf K0005596_summary.pdf K0005596_fulltext.pdf
著者 Thar Htet San|
発行日 2017-09-29
資料タイプ 学位論文
学位授与番号 甲第5596号
学位授与年月日 2017-09-29
学位・専攻分野 博士(医学)
授与大学 岡山大学
言語 英語
フルテキストURL BreastCancer_24_4_593.pdf BreastCancer_24_4_593_tbl_fig.pdf
著者 Saiga, Miho| Taira, Naruto| Kimata, Yoshihiro| Watanabe, Satoko| Mukai, Yuko| Shimozuma, Kojiro| Mizoo, Taeko| Nogami, Tomohiro| Iwamoto, Takayuki| Motoki, Takayuki| Shien, Tadahiko| Matsuoka, Junji| Doihara, Hiroyoshi|
キーワード BREAST-Q Breast cancer Breast reconstruction Health-related quality of life Satisfaction
発行日 2017-03
出版物タイトル Breast Cancer
24巻
2号
出版者 Japanese Breast Cancer Society
開始ページ 288
終了ページ 298
ISSN 1340-6868
NCID AA1103354X
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja
論文のバージョン author
PubMed ID 27179527
DOI 10.1007/s12282-016-0703-6
Web of Science KeyUT 000395524900012
関連URL isVerionOf https://doi.org/10.1007/s12282-016-0703-6